Keywords: nk-104, marketing, deal, japan, sankyo, kowa, copromote

NK-104 marketing deal in Japan

Article | 20 May 1999

Print This

Sankyo and Kowa will copromote Nissan Chemical'scholesterol-lowering drug NK-104 after it is approved for marketing in Japan. The drug is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in